번호 | 제목 | 게재수준 | 게재일자 |
---|---|---|---|
15 |
Methylprednisolone versus intravenous immune globulin as an initial therapy in adult primary immune thrombocytopenia
SCIE (Science Citation Index Expanded)
2019-03-01
|
SCIE (Science Citation Index Expanded) | 2019-03-01 |
14 |
Efficacy and safety of blinatumomab treatment in adult Korean patients with relapsed/refractory acute lymphoblastic leukemia on behalf of the Korean Society of Hematology ALL Working Party
SCIE (Science Citation Index Expanded)
2019-01-01
|
SCIE (Science Citation Index Expanded) | 2019-01-01 |
13 |
Clinical Characteristics of Temporal Bone Metastases
SCIE (Science Citation Index Expanded)
2019-01-01
|
SCIE (Science Citation Index Expanded) | 2019-01-01 |
12 |
Response to hypomethylating agents improves long-term outcomes for lower-risk patients with myelodysplastic syndrome in case-matched cohorts
SCIE (Science Citation Index Expanded)
2018-12-01
|
SCIE (Science Citation Index Expanded) | 2018-12-01 |
11 |
L-Deprenyl exerts cytotoxicity towards acute myeloid leukemia through inhibition of mitochondrial respiration
SCIE (Science Citation Index Expanded)
2018-12-01
|
SCIE (Science Citation Index Expanded) | 2018-12-01 |
10 |
No benefit of hypomethylating agents compared to supportive care for higher risk myelodysplastic syndrome
SCIE (Science Citation Index Expanded)
2018-11-01
|
SCIE (Science Citation Index Expanded) | 2018-11-01 |
9 |
The prognostic impact of lymphocyte subsets in newly diagnosed acute myeloid leukemia
SCOPUS
2018-09-28
|
SCOPUS | 2018-09-28 |
8 |
Pyrosequencing-based quantitative measurement of CALR mutation allele burdens and their clinical implications in patients with myeloproliferative neoplasms
SCIE (Science Citation Index Expanded)
2018-08-01
|
SCIE (Science Citation Index Expanded) | 2018-08-01 |
7 |
Chronic kidney disease in the BCR-ABL1-negative myeloproliferative neoplasm: a single-center retrospective study
SCIE (Science Citation Index Expanded)
2018-07-02
|
SCIE (Science Citation Index Expanded) | 2018-07-02 |
6 |
Comparison of standard-dose 3-weekly cisplatin and low-dose weekly cisplatin for concurrent chemoradiation of patients with locally advanced head and neck squamous cell cancer: A multicenter retrospective analysis
SCOPUS
2018-05-01
|
SCOPUS | 2018-05-01 |